Expression of c-myc, erbB-2,p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters

August 2005
Croatian Medical Journal;2005, Vol. 46 Issue 4, p717
Academic Journal
Presents an abstract of the study "Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters," by M. Sirotkovic-Skerlev et al.


Related Articles

  • Bcl-2 and N-Myc Coexpression Increases IGF-IR and Features of Malignant Growth in Neuroblastoma Cell Lines. Jasty, Rama; van Golen, Cynthia; Lin, Huey-Jen; Solomon, Gabe; Heidelberger, Kathleen; Polverini, Peter; Opipari, Anthony; Feldman, Eva; Castle, Valerie P // Neoplasia;Jul2001, Vol. 3 Issue 4, p304 

    The bcl-2 and c-myc oncogenes cooperate to transform multiple cell types. In the pediatric malignancy NB 2, Bcl-2 is highly expressed. In tumors with a poor prognosis, N-Myc, a protein homologous to c-Myc, is overexpressed as a result of gene amplification. The present study was designed to...

  • What retroviruses teach us about the involvement of c-Myc in leukemias and lymphomas. Dudley, J.P.; Mertz, J.A.; Rajan, L.; Lozano, M.; Broussard, D.R. // Leukemia (08876924);Jun2002, Vol. 16 Issue 6, p1086 

    Overexpression of the cellular oncogene c-Myc frequently occurs during induction of leukemias and lymphomas in many species. Retroviruses have enhanced our understanding of the role of c-Myc in such tumors. Leukemias and lymphomas induced by retroviruses activate c-Myc by: (1) use of virally...

  • The opposing roles of the Akt and c-Myc signalling pathways in survival from CD95-mediated apoptosis. Rohn, Jennifer L; Hueber, Anne-Odile; McCarthy, Nicola J; Lyon, Debbie; Navarro, Paloma; Burgering, Boudewijn M Th; Evan, Gerard I // Oncogene;12/3/98, Vol. 17 Issue 22, p2811 

    Expression of the proto-oncogene c-myc stimulates cell proliferation in the presence of the appropriate survival factors and triggers apoptosis in their absence; this dual capacity ensures that cell growth is restricted to the correct paracrine environment and is thereby strictly controlled....

  • Taking Myc to the Max. Turner, Richard // Nature Structural Biology;Mar2003, Vol. 10 Issue 3, p157 

    Discusses the results of a study of proto-oncogenes on the three-dimensional structure of the DNA-binding domain of c-Myc protein and its obligate DNA-binding partner protein Max. Description of the structures; Findings of an x-ray crystallographic analysis regarding the formation of dimers by...

  • Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Leone, Gustavo; DeGregori, James // Nature;5/22/1997, Vol. 387 Issue 6631, p422 

    Reports on the collaboration between Myc and Ras in inducing accumulation of active cyclin E/Cdk2 and E2F. The role of G1 cyclin-dependent kinase (CDK) in allowing the accumulation of E2F transcription factor activity and induction of the S phase of the cell cycle; What the study results show.

  • Sensitivity to myc-induced apoptosis is retained in spontaneous and transplanted lymphomas of CD2-mycERTM mice. Blyth, Karen; Stewart, Monica; Bell, Margaret; James, Clarwyn; Evan, Gerard; Neil, James C; Cameron, Ewan R // Oncogene;2/10/2000, Vol. 19 Issue 6, p773 

    To study the effects of the Myc oncoprotein in a regulatable in vivo system, we generated lines of transgenic mice in which a tamoxifen inducible Myc fusion protein (c-mycERTM) is expressed under the control of the CD2 locus control region. Activation of the Myc oncoprotein resulted in both...

  • Cancer biology: A genome-wide 'on' switch.  // Nature;10/11/2012, Vol. 490 Issue 7419, p146 

    The article offers information on the studies of Richard Young, Keji Zhao, and David Levens concerning the expression of gene c-Myc in human tumour cells.

  • Overexpression of c-Myc and cell immortalization alters c-Myc phosphorylation. Lutterbach, Bart; Hann, Stephen R // Oncogene;2/27/97, Vol. 14 Issue 8, p967 

    Using an extensive series of deletion and site-specific mutation constructs, we have identified five new phosphorylation sites in c-Myc in the N-terminal transactivation domain and near the C-terminal DNA binding/heterodimerization domain. We have also found that Thr-58 phosphorylation is...

  • Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1. Tan, Annie; Bitterman, Peter; Sonenberg, Nahum; Peterson, Mark; Polunovsky, Vitaly // Oncogene;3/9/2000, Vol. 19 Issue 11, p1437 

    Ectopically expressed eukaryotic translation initiation factor 4E (eIF4E) stimulates cell proliferation, suppresses apoptosis in growth factor restricted cells, and induces malignant transformation in primary rodent fibroblasts when coexpressed with protooncogene myc. We report here that eIF4E...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics